相关实验视频

Updated: Jun 12, 2025

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

化学CRISPR/dCas9FCPF:一种用于化学诱导表观基因组编辑的平台

Mukaddes Altinbay^1,2, Jianhui Wang^1,2, Jie Chen^1,2,3,4

¹Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt am Main, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.

Nucleic acids research

|September 24, 2024

概括

这项研究介绍了Chem-CRISPR/dCas9FCPF,一种新的表观基因组编辑平台. 它增强化学表观遗传抑制剂的特异性,克服与传统方法相关的毒性问题.

科学领域:

分子生物学分子生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
癌症研究癌症研究

背景情况:

表观遗传改变驱动癌症和化学疗法耐药性.
现有的表观遗传调节器面临着毒性和特异性的挑战.
克里斯普尔/dCas9提供精确的表观遗传调制,但存在传递和副作用的担忧.

研究的目的:

开发一种可化学诱导的表观基因组编辑平台.
使用CRISPR/dCas9技术增强表观遗传抑制剂的特异性.
为了解决当前表观遗传疗法的局限性.

主要方法:

将一个Phe-Cys-Pro-Phe (FCPF) - 标签集成到dCas9.
开发用于化学向的 perfluorobiphenyl (PFB) 衍生物.
化学抑制剂-PFB联合体的设计,以JQ1-PFB联合体为例.
应用Chem-CRISPR/dCas9FCPF系统用于在c-MYC促进体附近的向表观遗传调制.

主要成果:

建立了一个可化学诱导的表观基因组编辑平台 (Chem-CRISPR/dCas9FCPF).
证明c-MYC-sgRNA引导的JQ1-PFB在c-MYC促进体附近特别抑制BRD4.
与单独的JQ1相比,显示了c-MYC驱动的转录网络的有效抑制,具有更好的特异性.

结论:

化学CRISPR/dCas9FCPF平台显著提高了化学表观遗传抑制剂的标特异性.
该系统为表观基因组编辑提供了传统融合蛋白方法的可行替代方案.
为癌症治疗中的表观遗传调制提供了一种精确且潜在的少毒性方法.

更多相关视频

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...